Zobrazeno 61 - 70
of 145
pro vyhledávání: '"Muneer H. Abidi"'
Autor:
A. Samer Al-Homsi, Muneer H. Abidi, Marlee Muilenburg, Kelli Cole, Sarah Abdel-Mageed, Stephanie F. Williams, Austin Goodyke, Michael McLane
Publikováno v:
Blood. 128:4543-4543
The concept of suppressing dendritic cells (DCs) to prevent graft-versus-host disease (GvHD) following allogeneic hematopoietic stem cell transplantation (HSCT) has been rejuvenated since the introduction of proteasome inhibitors into clinical practi
Publikováno v:
Blood. 128:4635-4635
High-dose melphalan (M) followed by autologous hematopoietic stem cell transplantation (AHSCT) remains the standard treatment for multiple myeloma in eligible patients, even in the era of novel agents. However, the majority of patients ultimately rel
Autor:
Muthu, Veeraputhiran, Tania, Jain, Simon, Cronin, Zaid, Al-Kadhimi, Muneer H, Abidi, Lois, Ayash, Kendra, Mellert, Lawrence G, Lum, Voravit, Ratanatharathorn, Joseph P, Uberti, Abhinav, Deol
Publikováno v:
Journal of clinical apheresis. 29(6)
We report our experience of collecting stem cells in patients who failed to mobilize sufficient hematopoietic stem cell (HSC) using plerixafor (P) in the initial mobilization attempt. Twenty four patients were identified who failed a first mobilizati
Autor:
Natalie Dieterle, George Alangaden, Larry G Lum, Rami B. Ibrahim, Muneer H. Abidi, Simon Cronin, Shruti Patel
Publikováno v:
Journal of Oncology Pharmacy Practice. 15:187-189
A hematopoietic stem cell transplant patient with a history of immediate drug hypersensitivity reaction to micafungin was considered for a caspofungin trial. A caspofungin intradermal skin test was performed. The result was positive, suggesting the p
Autor:
Divaya Bhutani, Joseph P. Uberti, Jeffrey A. Zonder, Abhinav Deol, Lois Ayash, Muneer H. Abidi, Richard Manasa, Voravit Ratanatharathorn, Christine Ye, Lawrence G. Lum, Lakshminarayanan Nandagopal
Publikováno v:
Biology of Blood and Marrow Transplantation. 21:S199-S200
Publikováno v:
Journal of Oncology Pharmacy Practice. 12:119-121
This case report describes the use of palifermin in a multiple myeloma patient with a history of osteonecrosis of the jaw (ONJ) for the prevention of high-dose chemotherapy-induced mucositis. Following the day of autologous stem cell infusion, palife
Autor:
Muneer H. Abidi, Rishi Agarwal
Publikováno v:
Hematology Reports
Hematology Reports, Vol 4, Iss 4, Pp e26-e26 (2012)
Hematology Reports, Vol 4, Iss 4, Pp e26-e26 (2012)
Novel agents such as lenalidomide have demonstrated responses similar to high-dose melphalan and autologous stem cell transplant in multiple myeloma. For patients who are started on lenalidomide, it is advisable to collect stem cells early if future
Autor:
Kelli Cole, A. Samer Al-Homsi, Marlee Muilenburg, Ulrich Duffner, Aly A. Mageed, Stephanie F. Williams, Muneer H. Abidi
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:S387
Autor:
Abhinav Deol, Muneer H. Abidi, J.C. Ye, T. Lebeis, Joseph P. Uberti, Voravit Ratanatharathorn, Kendra Mellert, S. Hukku, Lois Ayash, Zaid Al-Kadhimi, Gail Bentley
Publikováno v:
Biology of Blood and Marrow Transplantation. 18(2)
Autor:
Muneer H. Abidi, Andy I. Chen, Tamas Masszi, Auayporn Nadamanee, Veronika Bachanova, Naomi N. H. Hunder, Patrick J. Stiff, Simonetta Viviani, Anna Sureda, Angelo Michele Carella, Dirk Huebner, Jan Walewski, Emily K. Larsen, Jerzy Holowiecki, Craig H. Moskowitz, Dzhelil Osmanov, John W. Sweetenham, Edward Agura
Publikováno v:
Blood. 126:3172-3172
Introduction The AETHERA trial is a phase 3, randomized, placebo-controlled trial (ClinicalTrials.gov #NCT01100502), which evaluated whether post-ASCT consolidation treatment with brentuximab vedotin (BV) could prevent disease progression in Hodgkin